Refine
Year of publication
- 2019 (6) (remove)
Document Type
- Article (6)
Language
- English (6)
Has Fulltext
- yes (6) (remove)
Is part of the Bibliography
- no (6)
Keywords
- - (6)
- <i>Bacillus subtilis</i> (1)
- <i>S. aureus</i> (1)
- Coagulation (1)
- Group B streptococcus (1)
- Hemolysis (1)
- Inflammation (1)
- Influenza A virus (1)
- Pigment (1)
- SNPs (1)
- antibacterial activity (1)
- biochemical-clinical traits (1)
- biomarker (1)
- carbon catabolite repression (1)
- eQTL (1)
- eicosanoids (1)
- infection (1)
- inhibition (1)
- lipid mediator (1)
- lipids (1)
- mQTL (1)
- metabolite (1)
- metabolomics (1)
- overflow metabolites (1)
- pig (1)
- pig model (1)
- proteomics (1)
- pyruvate (1)
- pyruvate kinase (1)
- snoD mutant (1)
- structure-activity (1)
- substituent (1)
- synthesis (1)
- tPMP resistance (1)
- transcript (1)
Institute
Publisher
- MDPI (4)
- Frontiers Media S.A. (1)
- S. Karger AG (1)
Prothrombotic and Proinflammatory Activities of the β-Hemolytic Group B Streptococcal Pigment
(2019)
A prominent feature of severe streptococcal infections is the profound inflammatory response that contributes to systemic toxicity. In sepsis the dysregulated host response involves both immunological and nonimmunological pathways. Here, we report a fatal case of an immunocompetent healthy female presenting with toxic shock and purpura fulminans caused by group B streptococcus (GBS; serotype III, CC19). The strain (LUMC16) was pigmented and hyperhemolytic. Stimulation of human primary cells with hyperhemolytic LUMC16 and STSS/NF-HH strains and pigment toxin resulted in a release of proinflammatory mediators, including tumor necrosis factor, interleukin (IL)-1β, and IL-6. In addition, LUMC16 induced blood clotting and showed factor XII activity on its surface, which was linked to the presence of the pigment. The expression of pigment was not linked to a mutation within the CovR/S region. In conclusion, our study shows that the hemolytic lipid toxin contributes to the ability of GBS to cause systemic hyperinflammation and interferes with the coagulation system.
Genetic Regulation of Liver Metabolites and Transcripts Linking to Biochemical-Clinical Parameters
(2019)
Given the central metabolic role of the liver, hepatic metabolites and transcripts reflect the organismal physiological state. Biochemical-clinical plasma biomarkers, hepatic metabolites, transcripts, and single nucleotide polymorphism (SNP) genotypes of some 300 pigs were integrated by weighted correlation networks and genome-wide association analyses. Network-based approaches of transcriptomic and metabolomics data revealed linked of transcripts and metabolites of the pentose phosphate pathway (PPP). This finding was evidenced by using a NADP/NADPH assay and HDAC4 and G6PD transcript quantification with the latter coding for first limiting enzyme of this pathway and by RNAi knockdown experiments of HDAC4. Other transcripts including ARG2 and SLC22A7 showed link to amino acids and biomarkers. The amino acid metabolites were linked with transcripts of immune or acute phase response signaling, whereas the carbohydrate metabolites were highly enrich in cholesterol biosynthesis transcripts. Genome-wide association analyses revealed 180 metabolic quantitative trait loci (mQTL) (p < 10-4). Trans-4-hydroxy-L-proline (p = 6 × 10-9), being strongly correlated with plasma creatinine (CREA), showed strongest association with SNPs on chromosome 6 that had pleiotropic effects on PRODH2 expression as revealed by multivariate analysis. Consideration of shared marker association with biomarkers, metabolites, and transcripts revealed 144 SNPs associated with 44 metabolites and 69 transcripts that are correlated with each other, representing 176 mQTL and expression quantitative trait loci (eQTL). This is the first work to report genetic variants associated with liver metabolite and transcript levels as well as blood biochemical-clinical parameters in a healthy porcine model. The identified associations provide links between variation at the genome, transcriptome, and metabolome level molecules with clinically relevant phenotypes. This approach has the potential to detect novel biomarkers displaying individual variation and promoting predictive biology in medicine and animal breeding.